This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Raze Therapeutics, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Mikel P Moyer: Innovator in Caffeine Inhibition
Introduction
Mikel P Moyer is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of caffeine inhibitors. With a total of 2 patents, Moyer's work focuses on innovative solutions that address specific biochemical challenges.
Latest Patents
Moyer's latest patents include "Caffeine inhibitors of MTHFD2 and uses thereof." This invention provides compounds and compositions that can be utilized in various applications. The methods outlined in his patents offer promising avenues for further research and development in the field.
Career Highlights
Mikel P Moyer is currently associated with Raze Therapeutics, Inc., where he continues to push the boundaries of scientific innovation. His work at the company emphasizes the importance of developing new therapeutic strategies that can improve health outcomes.
Collaborations
Moyer collaborates with esteemed colleagues such as Nello Mainolfi and Eddine Saiah. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.
Conclusion
Mikel P Moyer stands out as an influential inventor in the realm of caffeine inhibition. His contributions through patents and collaborations reflect his commitment to advancing scientific knowledge and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile